PMC:7652766 / 26018-26386
Annnotations
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T22","span":{"begin":0,"end":4},"obj":"Phenotype"},{"id":"T23","span":{"begin":76,"end":85},"obj":"Phenotype"}],"attributes":[{"id":"A22","pred":"hp_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"COPD patients are already considered more susceptible to the development of pneumonia based on the clinical characteristics exhibited, such as lung structural damage, alterations in local/systemic inflammatory response, impaired host immunity, microbiome imbalance, persistent mucus production, and the presence of potentially pathogenic bacteria in the airways (105)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T133","span":{"begin":0,"end":368},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"COPD patients are already considered more susceptible to the development of pneumonia based on the clinical characteristics exhibited, such as lung structural damage, alterations in local/systemic inflammatory response, impaired host immunity, microbiome imbalance, persistent mucus production, and the presence of potentially pathogenic bacteria in the airways (105)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1000","span":{"begin":54,"end":56},"obj":"Gene"},{"id":"1003","span":{"begin":5,"end":13},"obj":"Species"},{"id":"1013","span":{"begin":0,"end":4},"obj":"Disease"},{"id":"1014","span":{"begin":76,"end":85},"obj":"Disease"},{"id":"1015","span":{"begin":143,"end":165},"obj":"Disease"}],"attributes":[{"id":"A1000","pred":"tao:has_database_id","subj":"1000","obj":"Gene:6999"},{"id":"A1003","pred":"tao:has_database_id","subj":"1003","obj":"Tax:9606"},{"id":"A1013","pred":"tao:has_database_id","subj":"1013","obj":"MESH:D029424"},{"id":"A1014","pred":"tao:has_database_id","subj":"1014","obj":"MESH:D011014"},{"id":"A1015","pred":"tao:has_database_id","subj":"1015","obj":"MESH:D008171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"COPD patients are already considered more susceptible to the development of pneumonia based on the clinical characteristics exhibited, such as lung structural damage, alterations in local/systemic inflammatory response, impaired host immunity, microbiome imbalance, persistent mucus production, and the presence of potentially pathogenic bacteria in the airways (105)."}